Global Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
According to APO Research, The global Contraceptives market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
This report presents an overview of global market for Contraceptives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Contraceptives, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptives sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Contraceptives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Contraceptives sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc.
Contraceptives segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Contraceptives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
According to APO Research, The global Contraceptives market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
This report presents an overview of global market for Contraceptives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Contraceptives, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptives sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Contraceptives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Contraceptives sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc.
Contraceptives segment by Company
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Contraceptives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Contraceptives Market Size, 2019 VS 2023 VS 2030
1.3 Global Contraceptives Market Size Estimates and Forecasts (2019-2030)
1.4 Global Contraceptives Sales Estimates and Forecasts (2019-2030)
1.5 Global Contraceptives Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL CONTRACEPTIVES MARKET DYNAMICS
2.1 Contraceptives Industry Trends
2.2 Contraceptives Industry Drivers
2.3 Contraceptives Industry Opportunities and Challenges
2.4 Contraceptives Industry Restraints
3 CONTRACEPTIVES MARKET BY MANUFACTURERS
3.1 Global Contraceptives Revenue by Manufacturers (2019-2024)
3.2 Global Contraceptives Sales by Manufacturers (2019-2024)
3.3 Global Contraceptives Average Sales Price by Manufacturers (2019-2024)
3.4 Global Contraceptives Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Contraceptives Manufacturers, Product Type & Application
3.7 Global Contraceptives Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Contraceptives Market CR5 and HHI
3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2023
3.8.3 2023 Contraceptives Tier 1, Tier 2, and Tier
4 CONTRACEPTIVES MARKET BY TYPE
4.1 Contraceptives Type Introduction
4.1.1 Pills
4.1.2 Injectable
4.1.3 Condoms
4.1.4 Vaginal Rings
4.1.5 IUDs
4.1.6 Subdermal Implants
4.1.7 Others
4.2 Global Contraceptives Sales by Type
4.2.1 Global Contraceptives Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Contraceptives Sales by Type (2019-2030)
4.2.3 Global Contraceptives Sales Market Share by Type (2019-2030)
4.3 Global Contraceptives Revenue by Type
4.3.1 Global Contraceptives Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Contraceptives Revenue by Type (2019-2030)
4.3.3 Global Contraceptives Revenue Market Share by Type (2019-2030)
5 CONTRACEPTIVES MARKET BY APPLICATION
5.1 Contraceptives Application Introduction
5.1.1 15–24 years
5.1.2 25–34 years
5.1.3 35–44 years
5.1.4 Above 44 years
5.2 Global Contraceptives Sales by Application
5.2.1 Global Contraceptives Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Contraceptives Sales by Application (2019-2030)
5.2.3 Global Contraceptives Sales Market Share by Application (2019-2030)
5.3 Global Contraceptives Revenue by Application
5.3.1 Global Contraceptives Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Contraceptives Revenue by Application (2019-2030)
5.3.3 Global Contraceptives Revenue Market Share by Application (2019-2030)
6 GLOBAL CONTRACEPTIVES SALES BY REGION
6.1 Global Contraceptives Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Contraceptives Sales by Region (2019-2030)
6.2.1 Global Contraceptives Sales by Region (2019-2024)
6.2.2 Global Contraceptives Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Contraceptives Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Contraceptives Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Contraceptives Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Contraceptives Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL CONTRACEPTIVES REVENUE BY REGION
7.1 Global Contraceptives Revenue by Region
7.1.1 Global Contraceptives Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Contraceptives Revenue by Region (2019-2024)
7.1.3 Global Contraceptives Revenue by Region (2025-2030)
7.1.4 Global Contraceptives Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Contraceptives Revenue (2019-2030)
7.2.2 North America Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Contraceptives Revenue (2019-2030)
7.3.2 Europe Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Contraceptives Revenue (2019-2030)
7.4.2 Asia-Pacific Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Contraceptives Revenue (2019-2030)
7.5.2 LAMEA Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Bayer AG
8.1.1 Bayer AG Comapny Information
8.1.2 Bayer AG Business Overview
8.1.3 Bayer AG Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Bayer AG Contraceptives Product Portfolio
8.1.5 Bayer AG Recent Developments
8.2 Pfizer, Inc
8.2.1 Pfizer, Inc Comapny Information
8.2.2 Pfizer, Inc Business Overview
8.2.3 Pfizer, Inc Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Pfizer, Inc Contraceptives Product Portfolio
8.2.5 Pfizer, Inc Recent Developments
8.3 Teva Pharmaceutical Industries Ltd
8.3.1 Teva Pharmaceutical Industries Ltd Comapny Information
8.3.2 Teva Pharmaceutical Industries Ltd Business Overview
8.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
8.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
8.4 Merck & Co., Inc
8.4.1 Merck & Co., Inc Comapny Information
8.4.2 Merck & Co., Inc Business Overview
8.4.3 Merck & Co., Inc Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Merck & Co., Inc Contraceptives Product Portfolio
8.4.5 Merck & Co., Inc Recent Developments
8.5 Actavis, Inc.
8.5.1 Actavis, Inc. Comapny Information
8.5.2 Actavis, Inc. Business Overview
8.5.3 Actavis, Inc. Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Actavis, Inc. Contraceptives Product Portfolio
8.5.5 Actavis, Inc. Recent Developments
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Comapny Information
8.6.2 Johnson & Johnson Business Overview
8.6.3 Johnson & Johnson Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Johnson & Johnson Contraceptives Product Portfolio
8.6.5 Johnson & Johnson Recent Developments
8.7 Gedeon Richter
8.7.1 Gedeon Richter Comapny Information
8.7.2 Gedeon Richter Business Overview
8.7.3 Gedeon Richter Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Gedeon Richter Contraceptives Product Portfolio
8.7.5 Gedeon Richter Recent Developments
8.8 Novo Nordisk A/S
8.8.1 Novo Nordisk A/S Comapny Information
8.8.2 Novo Nordisk A/S Business Overview
8.8.3 Novo Nordisk A/S Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
8.8.5 Novo Nordisk A/S Recent Developments
8.9 ZiZhu
8.9.1 ZiZhu Comapny Information
8.9.2 ZiZhu Business Overview
8.9.3 ZiZhu Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 ZiZhu Contraceptives Product Portfolio
8.9.5 ZiZhu Recent Developments
8.10 Baijingyu
8.10.1 Baijingyu Comapny Information
8.10.2 Baijingyu Business Overview
8.10.3 Baijingyu Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Baijingyu Contraceptives Product Portfolio
8.10.5 Baijingyu Recent Developments
8.11 Huazhong
8.11.1 Huazhong Comapny Information
8.11.2 Huazhong Business Overview
8.11.3 Huazhong Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Huazhong Contraceptives Product Portfolio
8.11.5 Huazhong Recent Developments
8.12 Sine
8.12.1 Sine Comapny Information
8.12.2 Sine Business Overview
8.12.3 Sine Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Sine Contraceptives Product Portfolio
8.12.5 Sine Recent Developments
8.13 Reckitt
8.13.1 Reckitt Comapny Information
8.13.2 Reckitt Business Overview
8.13.3 Reckitt Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Reckitt Contraceptives Product Portfolio
8.13.5 Reckitt Recent Developments
8.14 AbbVie
8.14.1 AbbVie Comapny Information
8.14.2 AbbVie Business Overview
8.14.3 AbbVie Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 AbbVie Contraceptives Product Portfolio
8.14.5 AbbVie Recent Developments
8.15 Church & Dwight
8.15.1 Church & Dwight Comapny Information
8.15.2 Church & Dwight Business Overview
8.15.3 Church & Dwight Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Church & Dwight Contraceptives Product Portfolio
8.15.5 Church & Dwight Recent Developments
8.16 The Cooper Companies
8.16.1 The Cooper Companies Comapny Information
8.16.2 The Cooper Companies Business Overview
8.16.3 The Cooper Companies Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 The Cooper Companies Contraceptives Product Portfolio
8.16.5 The Cooper Companies Recent Developments
8.17 TherapeuticsMD
8.17.1 TherapeuticsMD Comapny Information
8.17.2 TherapeuticsMD Business Overview
8.17.3 TherapeuticsMD Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 TherapeuticsMD Contraceptives Product Portfolio
8.17.5 TherapeuticsMD Recent Developments
8.18 Afaxys
8.18.1 Afaxys Comapny Information
8.18.2 Afaxys Business Overview
8.18.3 Afaxys Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Afaxys Contraceptives Product Portfolio
8.18.5 Afaxys Recent Developments
8.19 Mithra Pharmaceuticals
8.19.1 Mithra Pharmaceuticals Comapny Information
8.19.2 Mithra Pharmaceuticals Business Overview
8.19.3 Mithra Pharmaceuticals Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
8.19.5 Mithra Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Contraceptives Value Chain Analysis
9.1.1 Contraceptives Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Contraceptives Production Mode & Process
9.2 Contraceptives Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Contraceptives Distributors
9.2.3 Contraceptives Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Contraceptives Market Size, 2019 VS 2023 VS 2030
1.3 Global Contraceptives Market Size Estimates and Forecasts (2019-2030)
1.4 Global Contraceptives Sales Estimates and Forecasts (2019-2030)
1.5 Global Contraceptives Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL CONTRACEPTIVES MARKET DYNAMICS
2.1 Contraceptives Industry Trends
2.2 Contraceptives Industry Drivers
2.3 Contraceptives Industry Opportunities and Challenges
2.4 Contraceptives Industry Restraints
3 CONTRACEPTIVES MARKET BY MANUFACTURERS
3.1 Global Contraceptives Revenue by Manufacturers (2019-2024)
3.2 Global Contraceptives Sales by Manufacturers (2019-2024)
3.3 Global Contraceptives Average Sales Price by Manufacturers (2019-2024)
3.4 Global Contraceptives Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Contraceptives Manufacturers, Product Type & Application
3.7 Global Contraceptives Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Contraceptives Market CR5 and HHI
3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2023
3.8.3 2023 Contraceptives Tier 1, Tier 2, and Tier
4 CONTRACEPTIVES MARKET BY TYPE
4.1 Contraceptives Type Introduction
4.1.1 Pills
4.1.2 Injectable
4.1.3 Condoms
4.1.4 Vaginal Rings
4.1.5 IUDs
4.1.6 Subdermal Implants
4.1.7 Others
4.2 Global Contraceptives Sales by Type
4.2.1 Global Contraceptives Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Contraceptives Sales by Type (2019-2030)
4.2.3 Global Contraceptives Sales Market Share by Type (2019-2030)
4.3 Global Contraceptives Revenue by Type
4.3.1 Global Contraceptives Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Contraceptives Revenue by Type (2019-2030)
4.3.3 Global Contraceptives Revenue Market Share by Type (2019-2030)
5 CONTRACEPTIVES MARKET BY APPLICATION
5.1 Contraceptives Application Introduction
5.1.1 15–24 years
5.1.2 25–34 years
5.1.3 35–44 years
5.1.4 Above 44 years
5.2 Global Contraceptives Sales by Application
5.2.1 Global Contraceptives Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Contraceptives Sales by Application (2019-2030)
5.2.3 Global Contraceptives Sales Market Share by Application (2019-2030)
5.3 Global Contraceptives Revenue by Application
5.3.1 Global Contraceptives Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Contraceptives Revenue by Application (2019-2030)
5.3.3 Global Contraceptives Revenue Market Share by Application (2019-2030)
6 GLOBAL CONTRACEPTIVES SALES BY REGION
6.1 Global Contraceptives Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Contraceptives Sales by Region (2019-2030)
6.2.1 Global Contraceptives Sales by Region (2019-2024)
6.2.2 Global Contraceptives Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Contraceptives Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Contraceptives Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Contraceptives Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Contraceptives Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Contraceptives Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL CONTRACEPTIVES REVENUE BY REGION
7.1 Global Contraceptives Revenue by Region
7.1.1 Global Contraceptives Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Contraceptives Revenue by Region (2019-2024)
7.1.3 Global Contraceptives Revenue by Region (2025-2030)
7.1.4 Global Contraceptives Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Contraceptives Revenue (2019-2030)
7.2.2 North America Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Contraceptives Revenue (2019-2030)
7.3.2 Europe Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Contraceptives Revenue (2019-2030)
7.4.2 Asia-Pacific Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Contraceptives Revenue (2019-2030)
7.5.2 LAMEA Contraceptives Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Bayer AG
8.1.1 Bayer AG Comapny Information
8.1.2 Bayer AG Business Overview
8.1.3 Bayer AG Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Bayer AG Contraceptives Product Portfolio
8.1.5 Bayer AG Recent Developments
8.2 Pfizer, Inc
8.2.1 Pfizer, Inc Comapny Information
8.2.2 Pfizer, Inc Business Overview
8.2.3 Pfizer, Inc Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Pfizer, Inc Contraceptives Product Portfolio
8.2.5 Pfizer, Inc Recent Developments
8.3 Teva Pharmaceutical Industries Ltd
8.3.1 Teva Pharmaceutical Industries Ltd Comapny Information
8.3.2 Teva Pharmaceutical Industries Ltd Business Overview
8.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
8.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
8.4 Merck & Co., Inc
8.4.1 Merck & Co., Inc Comapny Information
8.4.2 Merck & Co., Inc Business Overview
8.4.3 Merck & Co., Inc Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Merck & Co., Inc Contraceptives Product Portfolio
8.4.5 Merck & Co., Inc Recent Developments
8.5 Actavis, Inc.
8.5.1 Actavis, Inc. Comapny Information
8.5.2 Actavis, Inc. Business Overview
8.5.3 Actavis, Inc. Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Actavis, Inc. Contraceptives Product Portfolio
8.5.5 Actavis, Inc. Recent Developments
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Comapny Information
8.6.2 Johnson & Johnson Business Overview
8.6.3 Johnson & Johnson Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Johnson & Johnson Contraceptives Product Portfolio
8.6.5 Johnson & Johnson Recent Developments
8.7 Gedeon Richter
8.7.1 Gedeon Richter Comapny Information
8.7.2 Gedeon Richter Business Overview
8.7.3 Gedeon Richter Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Gedeon Richter Contraceptives Product Portfolio
8.7.5 Gedeon Richter Recent Developments
8.8 Novo Nordisk A/S
8.8.1 Novo Nordisk A/S Comapny Information
8.8.2 Novo Nordisk A/S Business Overview
8.8.3 Novo Nordisk A/S Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
8.8.5 Novo Nordisk A/S Recent Developments
8.9 ZiZhu
8.9.1 ZiZhu Comapny Information
8.9.2 ZiZhu Business Overview
8.9.3 ZiZhu Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 ZiZhu Contraceptives Product Portfolio
8.9.5 ZiZhu Recent Developments
8.10 Baijingyu
8.10.1 Baijingyu Comapny Information
8.10.2 Baijingyu Business Overview
8.10.3 Baijingyu Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Baijingyu Contraceptives Product Portfolio
8.10.5 Baijingyu Recent Developments
8.11 Huazhong
8.11.1 Huazhong Comapny Information
8.11.2 Huazhong Business Overview
8.11.3 Huazhong Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Huazhong Contraceptives Product Portfolio
8.11.5 Huazhong Recent Developments
8.12 Sine
8.12.1 Sine Comapny Information
8.12.2 Sine Business Overview
8.12.3 Sine Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Sine Contraceptives Product Portfolio
8.12.5 Sine Recent Developments
8.13 Reckitt
8.13.1 Reckitt Comapny Information
8.13.2 Reckitt Business Overview
8.13.3 Reckitt Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Reckitt Contraceptives Product Portfolio
8.13.5 Reckitt Recent Developments
8.14 AbbVie
8.14.1 AbbVie Comapny Information
8.14.2 AbbVie Business Overview
8.14.3 AbbVie Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 AbbVie Contraceptives Product Portfolio
8.14.5 AbbVie Recent Developments
8.15 Church & Dwight
8.15.1 Church & Dwight Comapny Information
8.15.2 Church & Dwight Business Overview
8.15.3 Church & Dwight Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Church & Dwight Contraceptives Product Portfolio
8.15.5 Church & Dwight Recent Developments
8.16 The Cooper Companies
8.16.1 The Cooper Companies Comapny Information
8.16.2 The Cooper Companies Business Overview
8.16.3 The Cooper Companies Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 The Cooper Companies Contraceptives Product Portfolio
8.16.5 The Cooper Companies Recent Developments
8.17 TherapeuticsMD
8.17.1 TherapeuticsMD Comapny Information
8.17.2 TherapeuticsMD Business Overview
8.17.3 TherapeuticsMD Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 TherapeuticsMD Contraceptives Product Portfolio
8.17.5 TherapeuticsMD Recent Developments
8.18 Afaxys
8.18.1 Afaxys Comapny Information
8.18.2 Afaxys Business Overview
8.18.3 Afaxys Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Afaxys Contraceptives Product Portfolio
8.18.5 Afaxys Recent Developments
8.19 Mithra Pharmaceuticals
8.19.1 Mithra Pharmaceuticals Comapny Information
8.19.2 Mithra Pharmaceuticals Business Overview
8.19.3 Mithra Pharmaceuticals Contraceptives Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
8.19.5 Mithra Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Contraceptives Value Chain Analysis
9.1.1 Contraceptives Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Contraceptives Production Mode & Process
9.2 Contraceptives Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Contraceptives Distributors
9.2.3 Contraceptives Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
